Ken Fisher’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Ken Fisher’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-35,270	Closed	-$173K	–	780
2016 Q4	$173K	Hold	35,270	–	–	﹤0.01%	698
2016 Q3	$175K	Hold	35,270	–	–	﹤0.01%	690
2016 Q2	$178K	Hold	35,270	–	–	﹤0.01%	669
2016 Q1	$226K	Hold	35,270	–	–	﹤0.01%	642
2015 Q4	$366K	Hold	35,270	–	–	﹤0.01%	603
2015 Q3	$651K	Buy	+35,270	New	+$681K	﹤0.01%	531

Other funds holding OSIR

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

FIM

Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Ken Fisher's OSIR Position: Q1 2017 in Review

Ken Fisher sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2017, closing a stake of 35,270 shares — an estimated $173K sold.

Ken Fisher first reported a position in OSIR in Q3 2015 and held it in 6 quarters. The position peaked at $651K in Q3 2015. 11 funds tracked by Wall St. Rank hold OSIR as of Q1 2017.

Ken Fisher reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
Ken Fisher sold 35,270 Osiris Therapeutics, Inc. Common Stock shares in Q1 2017, an estimated $173K.
Ken Fisher first reported a position in Osiris Therapeutics, Inc. Common Stock in Q3 2015 and held it in 6 quarters.
Ken Fisher's Osiris Therapeutics, Inc. Common Stock position peaked at $651K in Q3 2015.
11 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2017.

Based on Fisher Asset Management's 13F filing for Q1 2017, filed 25 Apr 2017.